SCOPUS 정보 검색 플랫폼

Canadian Journal of Ophthalmology

Volumn 39, Issue 6, 2004, Pages 656-661

The utility of multifocal electroretinography in monitoring drug toxicity: Deferoxamine retinopathy

(3) Kertes, Peter J a,b Lee, Thomas K M a Coupland, Stuart G a

a UNIVERSITY OF OTTAWA EYE INSTITUTE (Canada)

b SUNNYBROOK RESEARCH INSTITUTE (Canada)

Author keywords

Adverse effects; Deferoxamine mesylate; Drug toxicity; Multifocal electroretinography

Indexed keywords

DEFEROXAMINE;

AGED; ARTICLE; BLOOD TRANSFUSION; CASE REPORT; CLINICAL FEATURE; ELECTRORETINOGRAPHY; ERYTHROCYTE COUNT; FEMALE; HUMAN; KERATOPATHY; OPHTHALMOSCOPY; PIGMENT EPITHELIUM; RETINOPATHY; SLIT LAMP; VISUAL ACUITY;

EID: 8144228259 PISSN: 00084182 EISSN: 17153360 Source Type: Journal
DOI: 10.1016/S0008-4182(04)80031-0 Document Type: Article

Times cited : (15)

References (9)

1
- 0031457203
- A risk-benefit assessment of iron chelation therapy
- Porter JB. A risk-benefit assessment of iron chelation therapy. Drug Saf 1997;17:407-21.
- (1997) Drug Saf , vol.17 , pp. 407-421
- Porter, J.B.¹

2
- 0020146403
- Transfusional hemosiderosis and chelation therapy
- Ley TJ, Griffith P, Nienhuis AW. Transfusional hemosiderosis and chelation therapy. Clin Haematol 1982;11: 437-64.
- (1982) Clin Haematol , vol.11 , pp. 437-464
- Ley, T.J.¹ Griffith, P.² Nienhuis, A.W.³

3
- 0017845836
- Lens opacities in thalassemia
- Bloomfield SE, Markenson AL, Miller DR, Peterson CM. Lens opacities in thalassemia. J Pediatr Ophthalmol Strabismus 1987;15:154-6.
- (1987) J Pediatr Ophthalmol Strabismus , vol.15 , pp. 154-156
- Bloomfield, S.E.¹ Markenson, A.L.² Miller, D.R.³ Peterson, C.M.⁴

4
- 0021289327
- Deferoxamine (Desferal)-induced toxic retinal pigmentary degeneration and presumed optic neuropathy
- Lakhanpal V, Schocket SS, Jiji R. Deferoxamine (Desferal)-induced toxic retinal pigmentary degeneration and presumed optic neuropathy. Ophthalmology 1984;91: 443-51.
- (1984) Ophthalmology , vol.91 , pp. 443-451
- Lakhanpal, V.¹ Schocket, S.S.² Jiji, R.³

5
- 0020577339
- Ocular toxicity of high-dose intravenous desferrioxamine
- Davies SC, Marcus RE, Hungerford JL, Miller MH, Arden GB, Huehns ER. Ocular toxicity of high-dose intravenous desferrioxamine. Lancet 1983;2:181-4.
- (1983) Lancet , vol.2 , pp. 181-184
- Davies, S.C.¹ Marcus, R.E.² Hungerford, J.L.³ Miller, M.H.⁴ Arden, G.B.⁵ Huehns, E.R.⁶

6
- 0022628511
- Visual and auditory neurotoxicity in patients receiving subcutaneous deferoxamine infusions
- Olivieri NF, Buncic JR, Chew E, Gallant T, Harrison RV, Keenan N, et al. Visual and auditory neurotoxicity in patients receiving subcutaneous deferoxamine infusions. N Engl J Med 1986;314:869-73.
- (1986) N Engl J Med , vol.314 , pp. 869-873
- Olivieri, N.F.¹ Buncic, J.R.² Chew, E.³ Gallant, T.⁴ Harrison, R.V.⁵ Keenan, N.⁶

7
- 0036136409
- The expanded clinical spectrum of deferoxamine retinopathy
- Haimovici R, D'Amico DJ, Gragoudas ES, Sokol S; Deferoxamine Retinopathy Study Group. The expanded clinical spectrum of deferoxamine retinopathy. Ophthalmology 2002;109:164-71.
- (2002) Ophthalmology , vol.109 , pp. 164-171
- Haimovici, R.¹ D'Amico, D.J.² Gragoudas, E.S.³ Sokol, S.⁴

8
- 0036288931
- Recommendations on screening for chloroquine and hydroxychloroquine retinopathy
- Marmor MF, Carr RE, Easterbrook M, Farjo AA, Mieler WF. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Ophthalmology 2002; 109:1377-82.
- (2002) Ophthalmology , vol.109 , pp. 1377-1382
- Marmor, M.F.¹ Carr, R.E.² Easterbrook, M.³ Farjo, A.A.⁴ Mieler, W.F.⁵

9
- 0026541378
- The field topography of ERG components in man: I. The photopic luminance response
- Sutler EE, Tran D. The field topography of ERG components in man: I. The photopic luminance response. Vision Res 1992;32:433-46.
- (1992) Vision Res , vol.32 , pp. 433-446
- Sutler, E.E.¹ Tran, D.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.